Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B UNITED STATES — Net Sales

Similar metrics at other companies

Lamb Weston logo
LWUnited States — Net Sales
$1.04B-2.4%
The Cooper Companies, Inc. logo
COOUnited States — Net Sales
$547.8M+6.3%
Ingram Micro logo
INGMUnited States — Net Sales
$4.51B+10.1%
Medtronic logo
MDTUnited States — Net Sales
$4.87B+7.1%
GameStop logo
GMEUnited States — Net Sales
$651.1M+21.1%
Tempur Sealy International logo
SGIUnited States — Net Sales
$1.39B+12.0%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s united states — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s UNITED STATES — net sales?
Bio-Rad Laboratories, Inc. (BIO.B) reported UNITED STATES — net sales of $229.8M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s UNITED STATES — net sales changed year-over-year?
Bio-Rad Laboratories, Inc.'s UNITED STATES — net sales decreased by 4.9% year-over-year, from $241.7M to $229.8M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s UNITED STATES — net sales?
Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s UNITED STATES — net sales has grown at a -2.5% compound annual growth rate (CAGR), from $1.13B to $1.02B.
What does UNITED STATES — net sales mean?
This metric represents the total revenue generated from the sale of goods and services within the United States geographic segment. It reflects the company's market penetration and demand for clinical diagnostics and life science products in this specific region. This figure is a primary indicator of regional business performance and market share stability.